Genomic Testing Cooperative Highlights Expanded Role of CSF-Based Molecular Profiling Following NCCN Update

Genomic Testing Cooperative (GTC) today highlighted its Liquid Trace® cerebrospinal fluid (CSF)-based molecular profiling ...
Targeted Oncology

NCCN Now Backs CSF Genomic Testing in Gliomas When Biopsy Isn't Possible

NCCN now endorses CSF-based profiling for biopsy-infeasible HGG/GBM to enable molecular characterization required for ...
Medical Xpress

Study finds the timing of CSF biomarker divergence for Alzheimer disease, normal cognition varies

Cerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to six years before ...
Hosted on MSN

Groundbreaking new brain cancer test has an 80% accuracy rate with no false positives

For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI scans may reveal a suspicious-looking lesion, but the only sure way to ...

Body Fluid Analysis Market worth $3.65 billion by 2031 | MarketsandMarkets™

According to MarketsandMarkets™, the Body Fluid Analysis Market is projected to grow from about USD 2.62 billion in 2026 to ...